Skip to content

Effects of Glycyrrhiza Glabra on Obese Subjects

Effects of Dried Extract of Glycyrrhiza Glabra Root with Weight Loss Diet on Anthropometric Indices, Vaspin Hormone, Zinc a2- glycoprotein and Lipid Profile in Obese Subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013062811288N3
Enrollment
54
Registered
2013-08-29
Start date
2013-04-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Obesity due to excess calories

Interventions

Intervention 1: Intervention group:Consumption of 1.5 gr Glycyrrhiza Glabra Root supplement (500 mg capsules three times a day) with weight loss diet. Intervention 2: Control group:1.5 gr starch(500 m
Treatment - Other
Treatment - Drugs
Intervention group:Consumption of 1.5 gr Glycyrrhiza Glabra Root supplement (500 mg capsules three times a day) with weight loss diet
Control group:1.5 gr starch(500 mg capsules three times a day) with weight loss diet

Sponsors

Nutrition Research Center, Health and nutrition faculty, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: BMI equal or greater than 25; subjects with 25-50 years old;following no weight loss or any special diet during 6 months ago. Exclusion criteria: vitamin and mineral supplement consumption, losing weight drugs during 3 months age;pregnancy or lactation; smoking; 5-being hypertention,cardiovascular diseases,diabetes,liver,kindney,tyroid,types 1 or 2 diabetes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lipid profile mesearment. Timepoint: Beginning and the end of the intervention. Method of measurement: TC,TG,HDL-C,LDL-C mesearment with special kits.;Anthropometric indices. Timepoint: Beginning and the end of the intervention. Method of measurement: Weight,height,waist circumference and hip circumference mesearments.

Secondary

MeasureTime frame
Vaspin hormone. Timepoint: Begining and the end of intervention. Method of measurement: ELISA method.;Zinc a2- glycoprotein. Timepoint: Begining and the end of intervention. Method of measurement: ELISA method.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026